Solaraze

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2014
01220032014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Interest is increasing in the use of sequential or combined therapeutic modalities for spot or area treatment of actinic… (More)
  • table 1
Is this relevant?
2011
2011
The objective of the study was to investigate the effect of laser microporation, using P.L.E.A.S.E.® technology, on diclofenac… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2011
2011
  • Solaraze diclofenac
  • 2011
Rx Only FOR DERMATOLOGIC USE ONLY. NOT FOR OPHTHALMIC USE. DESCRIPTION Solaraze (diclofenac sodium) Gel, 3%, contains the active… (More)
  • table 1
Is this relevant?
2007
2007
OBJECTIVES AND METHODS This study is an evaluation of patients diagnosed with actinic keratosis (AK) lesions of the upper and… (More)
Is this relevant?
2006
2006
Topical treatment with 3% diclofenac in 2.5% hyaluronic acid (Solaraze) has been extensively documented for the treatment of… (More)
Is this relevant?
2004
2004
A clearance rate of all occurrences > or = 75% for actinic keratoses (AK) lesions is an accepted efficacy endpoint for topical… (More)
Is this relevant?
2004
2004
Actinic Keratoses (AKs) are epidermal skin lesions that have the potential to develop into squamous cell carcinoma. Many of the… (More)
  • table 1
  • table 1
  • figure 1
  • figure 2
  • figure 2
Is this relevant?
Review
2003
Review
2003
Topical 3% diclofenac in 2.5% hyaluronic acid (HA) gel (diclofenac HA gel; Solaraze) is an NSAID approved for the treatment of… (More)
Is this relevant?
2003
2003
  • Jane Young
  • The Journal of dermatological treatment
  • 2003
 
Is this relevant?